BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25167)

  • 1. Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 Mar; 15(3):198-217. PubMed ID: 25167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenylate cyclase from various dopaminergic areas of the brain and the action of loxapine.
    Clement-Cormier YC
    Adv Exp Med Biol; 1977; 90():183-90. PubMed ID: 930743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients.
    Kiloh LG; Williams SE; Grant DA; Whetton PS
    J Int Med Res; 1976; 4(6):441-8. PubMed ID: 800384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of loxitane--loxapine succinate and trifluoperazine hydrochloride in chronic schizophrenic patients.
    Moyano CZ
    Dis Nerv Syst; 1975 Jun; 36(6):301-4. PubMed ID: 238810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3H-Spiroperidol binding to dopamine receptors in rat striatal membranes: influence of loxapine and its hydroxylated metabolites.
    Coupet J; Rauh CE
    Eur J Pharmacol; 1979 Apr; 55(2):215-8. PubMed ID: 456420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
    Sayers AC; Bürki HR; Ruch W; Asper H
    Psychopharmacologia; 1975; 41(2):97-104. PubMed ID: 1171492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of loxapine succinate in acute schizophrenia: a comparative study with thiothixene.
    van der Velde CD; Kiltie H
    Curr Ther Res Clin Exp; 1975 Jan; 17(1):1-12. PubMed ID: 806422
    [No Abstract]   [Full Text] [Related]  

  • 8. Loxapine update: 1966-1976.
    Ayd FJ
    Dis Nerv Syst; 1977 Nov; 38(11):883-7. PubMed ID: 410614
    [No Abstract]   [Full Text] [Related]  

  • 9. Does loxapine have "atypical" properties? Clinical evidence.
    Glazer WM
    J Clin Psychiatry; 1999; 60 Suppl 10():42-6. PubMed ID: 10340686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind comparison of loxapine succinate and trifluoperazine in newly admitted schizophrenic patients.
    Simpson GM; Cuculic Z
    J Clin Pharmacol; 1976 Jan; 16(1):60-5. PubMed ID: 1107360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of loxapine succinate in the treatment of schizophrenia: a comparative study with thiothixene.
    Vianna Filho U; Versiani Caldeira V; Romildo Bueno J
    Curr Ther Res Clin Exp; 1975 Sep; 18(3):476-90. PubMed ID: 810308
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of antipsychotic drugs on body weight: a retrospective review.
    Doss FW
    J Clin Psychiatry; 1979 Dec; 40(12):528-30. PubMed ID: 40965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain.
    Lee T; Tang SW
    Psychiatry Res; 1984 Aug; 12(4):277-85. PubMed ID: 6239298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loxapine versus chlorpromazine in paranoid schizophrenia: a double-blind study.
    Tuason VB; Escobar JI; Garvey M; Schiele B
    J Clin Psychiatry; 1984 Apr; 45(4):158-63. PubMed ID: 6370967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of loxapine in the treatment of paranoid schizophrenia.
    Bishop MP; Simpson GM; Dunnett CW; Kiltie H
    Psychopharmacology (Berl); 1977 Jan; 51(2):107-15. PubMed ID: 14350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute schizophrenia with loxapine succinate (Loxitane) in a controlled study with chlorpromazine.
    Moore DF
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):172-80. PubMed ID: 809232
    [No Abstract]   [Full Text] [Related]  

  • 17. Loxapine succinate: a controlled double-blind study in chronic schizophrenia.
    Schiele BC
    Dis Nerv Syst; 1975 Jul; 36(7):361-4. PubMed ID: 1097221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
    Tuason VB
    J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
    Selman FB; McClure RF; Helwig H
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):645-52. PubMed ID: 819222
    [No Abstract]   [Full Text] [Related]  

  • 20. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS; Spencer CM
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.